Acg Wealth Mustang Bio, Inc. Transaction History

Acg Wealth

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$2.7 - $3.81 $67,481 - $95,223	-24,993 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$3.02 - $5.16 $54,360 - $92,880	-18,000 Reduced 41.87%	24,993 $83,000
Q3 2020 Nov 12, 2020	BUY	$3.01 - $3.88 $129,408 - $166,812	42,993 New	42,993 $135,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $24.2M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

Stay updated on Acg Wealth with notifications on news.